Global Pressure Ulcer Device Market to Reach US$ 9,380.8 million by 2034| Fact.MR

The global pressure ulcer device market is expected to be valued at USD 5,460.8 million in 2024. It is projected to grow at a steady CAGR of 5.6% over the forecast period, reaching a market value of USD 9,380.8 million by 2034.

For More Insights into the Market, Request a Sample of this Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=9681

Pressure ulcers, commonly known as bedsores, are injuries to the skin and underlying tissue resulting from prolonged pressure on the skin. They are prevalent among individuals with limited mobility, particularly the elderly and chronically ill. The increasing global aging population, coupled with a rise in chronic conditions such as diabetes and cardiovascular diseases, has led to a higher incidence of pressure ulcers, thereby driving the demand for effective prevention and management devices.

Key Market Drivers

Aging Population and Chronic Diseases:

The global demographic shift towards an older population has resulted in a higher prevalence of chronic illnesses and reduced mobility, increasing the risk of pressure ulcers. This demographic trend is a significant driver for the pressure ulcer device market.

Technological Innovations:

Advancements in medical technology have led to the development of sophisticated pressure ulcer devices, including smart surfaces, wearable monitoring devices, and advanced materials that enhance patient outcomes.

Increased Healthcare Awareness:

There is a growing awareness among healthcare professionals, caregivers, and patients about the impact of pressure ulcers on health and quality of life, leading to a proactive approach in prevention and management, thereby boosting the market for related devices.

Market Restraints

Despite the positive growth trajectory, the market faces certain challenges:

High Costs: The advanced technology and materials used in pressure ulcer devices contribute to higher costs, which can be a barrier to adoption, especially in developing regions.

Limited Reimbursement Policies: The absence of comprehensive reimbursement policies for pressure ulcer treatments in many countries poses a significant challenge, affecting the financial accessibility of patients seeking care.

Regional Insights

North America:

The region holds a dominant share of 38.7% in the global market, driven by advanced healthcare infrastructure and high awareness levels.

Asia-Pacific:

Expected to witness the fastest growth at a CAGR of 6.53% from 2024 to 2031, attributed to the increasing elderly population and rising prevalence of chronic diseases.

Pressure Ulcer Device Market - Key Segments

By Product Type:

Mattress Overlays
Pressure Relief Mattresses
Specialty Beds
Pressure Relief Cushions
Alternating Pressure Wheelchair's Cushions
Off-Loading Devices
Pressure Relief Accessories
Advanced Wound Dressings

By Stages:

Stage I
Stage II
Stage III
Stage IV

By End-User:

Hospitals
Long-term Care Centres
Skilled Nursing Facilities
Home Care Settings


Key Players:

Some of the key players operating in the pressure ulcer devices market are Stryker Corp., Smith & Nephew Plc., Hill-Rom Services Inc., Paramount Bed Holdings Co., Ltd., Apex Medical Corp., Medtronic, DARCO International, DeRoyal Industries, Talley Group Limited, and LINET.

Recent Developments

Baxter has introduced the Envella Air Fluidized Therapy (AFT) Bed, designed to facilitate quicker and more comfortable healing for patients by creating a fluid-like environment that enhances immersion and envelopment, reducing shear and pressure.

LINET launched the Air2Care mattress line, specifically designed for hospitals and long-term care facilities, integrating a 2-cell alternating system to effectively prevent pressure injuries.

Browse Full Report: https://www.factmr.com/report/pressure-ulcer-device-market

Future Outlook

The pressure ulcer device market is expected to continue its growth trajectory, driven by technological advancements, increasing healthcare awareness, and the rising prevalence of chronic diseases. However, addressing the challenges related to high costs and reimbursement policies will be crucial for sustained growth and wider adoption of these devices

Check out More Related Studies Published by Fact.MR:

Ulcerative Colitis Therapeutics Market: https://www.factmr.com/report/ulcerative-colitis-therapeutics-market

Speech Generating Device Market: https://www.factmr.com/report/53/speech-generating-devices-market

Pressure Ulcer Relief Products Market: https://www.factmr.com/report/pressure-ulcer-relief-products-market

3D Printing Medical Device Market: https://www.factmr.com/report/248/3d-printing-medical-devices-market

Contact:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

About Fact.MR

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.